WAY

Waystar Holding Corp

37.47 USD
+0.11
0.29%
At close Jan 17, 4:00 PM EST
After hours
37.47
+0.00
0.00%
1 day
0.29%
5 days
1.27%
1 month
5.58%
3 months
35.81%
6 months
67.28%
Year to date
4.23%
1 year
81.01%
5 years
81.01%
10 years
81.01%
 

About: Waystar Holding Corp is a provider of mission-critical cloud technology to healthcare organizations. its enterprise-grade platform transforms the complex and disparate processes comprising healthcare payments received by healthcare providers from payers and patients, from pre-service engagement through post-service remittance and reconciliation. its platform enhances data integrity, eliminates manual tasks, and improves claim and billing accuracy, which results in better transparency, reduced labor costs, and faster, more accurate reimbursement and cash flow. The market for our solutions extends throughout the United States and includes Puerto Rico and other US Territories.

Employees: 1,400

0
Funds holding %
of 6,823 funds
0
Analysts bullish %
of 6 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 2 [Q2] → 4 (+2) [Q3]

86% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 29

43% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 21

26% more funds holding

Funds holding: 92 [Q2] → 116 (+24) [Q3]

25% more capital invested

Capital invested by funds: $2.71B [Q2] → $3.39B (+$680M) [Q3]

2.71% less ownership

Funds ownership: 75.69% [Q2] → 72.98% (-2.71%) [Q3]

99% less call options, than puts

Call options by funds: $8K | Put options by funds: $1.38M

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$34
9%
downside
Avg. target
$40
6%
upside
High target
$44
17%
upside

6 analyst ratings

positive
100%
neutral
0%
negative
0%
Goldman Sachs
Adam Hotchkiss
90% 1-year accuracy
18 / 20 met price target
17%upside
$44
Buy
Maintained
14 Jan 2025
B of A Securities
Allen Lutz
69% 1-year accuracy
9 / 13 met price target
15%upside
$43
Buy
Maintained
6 Jan 2025
Canaccord Genuity
Richard Close
59% 1-year accuracy
16 / 27 met price target
12%upside
$42
Buy
Maintained
3 Jan 2025
Raymond James
Brian Peterson
45% 1-year accuracy
10 / 22 met price target
7%upside
$40
Strong Buy
Upgraded
22 Nov 2024
RBC Capital
Sean Dodge
48% 1-year accuracy
21 / 44 met price target
9%downside
$34
Outperform
Maintained
7 Nov 2024

Financial journalist opinion

Based on 5 articles about WAY published over the past 30 days

Positive
CNBC
6 days ago
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Companies from Johnson & Johnson to Eli Lilly, Amazon and Nvidia are announcing health-related deals at the JPMorgan Health Care Conference.
Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals
Neutral
PRNewsWire
1 week ago
Waystar unveils transformative generative AI innovation to help providers recover billions of dollars tied to 450 million annual denied claims
Healthcare providers gain access to first-of-its-kind generative AI technology, leading to faster and more accurate payments LEHI, Utah, and LOUISVILLE, Ky. , Jan. 13, 2025 /PRNewswire/ -- Waystar (Nasdaq: WAY), a provider of leading healthcare payment software, today announced the launch of Waystar AltitudeAI™, a comprehensive set of AI capabilities for providers, including AltitudeCreate™, a new generative AI innovation focused on appealing denied claims.
Waystar unveils transformative generative AI innovation to help providers recover billions of dollars tied to 450 million annual denied claims
Neutral
PRNewsWire
2 weeks ago
Waystar to Present at J.P. Morgan Healthcare Conference
LEHI, Utah and LOUISVILLE, Ky. , Jan. 6, 2025 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will present at the 43rd Annual J.P.
Waystar to Present at J.P. Morgan Healthcare Conference
Neutral
PRNewsWire
3 weeks ago
Waystar Announces Amendment to Its Credit Facilities
Enhancements expected to boost flexibility and lower borrowing costs LEHI, Utah and LOUISVILLE, Ky. , Dec. 30, 2024 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced an amendment to its first lien credit agreement (the "amended credit agreement") with its lenders.
Waystar Announces Amendment to Its Credit Facilities
Negative
CNBC
3 weeks ago
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
It's been nearly five years since the coronavirus broke out in the U.S., but digital health companies are still reeling from the aftermath. According to a CNBC analysis of 39 public digital health companies, around two-thirds have lost value this year, while the Nasdaq is up 32%.
Digital health companies got pummeled by Wall Street in 2024 as industry adapts to post-Covid slowdown
Neutral
PRNewsWire
1 month ago
Waystar Named One of Forbes' Most Trusted Companies in America
LEHI, Utah, and LOUISVILLE, Ky. , Dec. 4, 2024 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, announced today that Forbes recognized Waystar as one of the Most Trusted Companies in America, alongside many of the world's leading software companies.
Waystar Named One of Forbes' Most Trusted Companies in America
Neutral
PRNewsWire
1 month ago
Waystar to Speak at Upcoming Investor Conferences
LEHI, Utah and LOUISVILLE, Ky. , Nov. 26, 2024 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today announced that Chief Executive Officer Matt Hawkins will speak at two upcoming investor conferences: Evercore ISI HealthCONx Conference on Wednesday, December 4, 2024, at 1:20 p.m.
Waystar to Speak at Upcoming Investor Conferences
Neutral
PRNewsWire
2 months ago
Waystar Reports Third Quarter 2024 Results
Revenue growth of 22% year-over-year Net income of $5.4 million and non-GAAP net income of $25.3 million Net income margin of 2%; Adjusted EBITDA margin of 40% LEHI, Utah and LOUISVILLE, Ky. , Nov. 6, 2024 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, today reported results for the three-month period ended September 30, 2024.
Waystar Reports Third Quarter 2024 Results
Neutral
Seeking Alpha
3 months ago
Global IPO Activity Picking Up But Continues To Lag Other Post-COVID Years
Global IPO activity is recovering but remains below recent years, with 326 IPOs in Q3 2024 totaling $23.32 billion, the lowest since Q1 2019. US IPO activity has increased steadily, with 36 IPOs in Q3 2024, and $26.28 billion raised in the first three quarters, nearly double 2023. European IPO activity slowed in Q3 2024, with 30 transactions and $770 million offered, but $17.46 billion raised through Q3 2024, up from $13.50 billion in 2023.
Global IPO Activity Picking Up But Continues To Lag Other Post-COVID Years
Neutral
PRNewsWire
3 months ago
Waystar to Announce Third Quarter 2024 Financial Results on November 6, 2024
LEHI, Utah and LOUISVILLE, Ky. , Oct. 14, 2024 /PRNewswire/ -- Waystar Holding Corp. (Nasdaq: WAY), a provider of leading healthcare payment software, announced today that it will report financial results for the third quarter ended September 30, 2024, after market close on Wednesday, November 6, 2024.
Waystar to Announce Third Quarter 2024 Financial Results on November 6, 2024
Charts implemented using Lightweight Charts™